Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated Steatohepatitis
Clinics in Liver Disease · 2026
DOI: 10.1016/j.cld.2025.12.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2026. Verfasst von Angelo Armandi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: https://twitter.com/AngeloArmandi. Hauptthemen laut MEDLINE: Algorithms, Fatty Liver, Liver Cirrhosis, Metabolic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: https://twitter.com/AngeloArmandi.
- Department of Medical Sciences, University of Turin, Turin, Italy.
- Division of Gastroenterology and Hepatology, MASLD Research Center, University of California at San Diego, La Jolla, CA, USA.
- Department of Endocrinology, Diabetes and Nutrition, Lyon South Hospital, Hospices Civils de Lyon and Lyon 1 University, Lyon, France. Electronic address: cyrielle.caussy@chu-lyon.fr.
Zitieren
APA
Armandi, A., Bugianesi, E., Loomba, R., & Caussy, C. (2026). Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated Steatohepatitis. Clinics in Liver Disease. https://doi.org/10.1016/j.cld.2025.12.005
Vancouver
Armandi A, Bugianesi E, Loomba R, Caussy C. Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated Steatohepatitis. Clinics in Liver Disease. 2026. doi:10.1016/j.cld.2025.12.005
BibTeX
@article{Armandi2026,
author = {Armandi, Angelo and Bugianesi, Elisabetta and Loomba, Rohit and Caussy, Cyrielle},
title = {Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated Steatohepatitis},
journal = {Clinics in Liver Disease},
year = {2026},
doi = {10.1016/j.cld.2025.12.005}
}
EUVIMED